{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:28:08Z","timestamp":1788672488022,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Dysphagia is a life-threating manifestation of idiopathic inflammatory myopathies (IIM). However, we lack a univocal protocol for its treatment. The aim of this retrospective analysis was to evaluate the effectiveness of a step-up strategy by adding a 1-day pulse of IVIGs to immunosuppressants in IIM patients with refractory dysphagia diagnosed by Eating Assessment Tool (EAT)-10 and fibreoptic endoscopic evaluation of swallowing (FEES).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Dysphagia was defined as a pharyngo-oesophageal disturbance associated with EAT-10 score \u22653 and at least one FEES abnormality among propulsion failure, solid or liquid stasis. Eighteen out of 154 IIM patients had FEES-confirmed dysphagia and underwent 1\u2009day IVIG 2\u2009g\/kg repeated 1\u2009month apart for 3\u2009months, because of dysphagia refractory to high-dose glucocorticoids with methotrexate and\/or azathioprine. Clinical characteristics along with myositis-specific antibodies and muscle histopathological findings were studied in FEES-dysphagia IIM and IIM control patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>After three monthly doses of IVIG, EAT-10 score dropped with complete recover of defective propulsion and progressive decrease in percentage of both solid and liquid stasis. At 52-weeks\u2019 follow-up, reached in 12 patients, all these parameters were stable or further improved. An improvement in manual muscle strength test and a steroid-sparing effect of IVIG were also observed. Anti-PM\/Scl 75\/100 antibodies were much more frequent in the FEES-dysphagia group, while anti-Jo1 antibody was rarely detected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our treatment schedule with 2\u2009g\/kg IVIG was effective for IIM-associated refractory dysphagia assessed by the combination of EAT-10 and FEES. These findings need to be prospectively tested in a larger cohort of IIM patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa443","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T19:10:49Z","timestamp":1593630649000},"page":"1234-1242","source":"Crossref","is-referenced-by-count":19,"title":["Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4834-5804","authenticated-orcid":false,"given":"Margherita","family":"Giannini","sequence":"first","affiliation":[{"name":"Rheumatology Unit, University of Bari, D.E.T.O, Bari, Italy"},{"name":"Service de Physiologie et d\u2019Explorations fonctionnelles, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Fiorella","sequence":"additional","affiliation":[{"name":"Departement of Basic Medical Sciences, Neuroscience and Sense Organs, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Tampoia","sequence":"additional","affiliation":[{"name":"A.O.U.C. Policlinico Bari, Clinical Pathology Unit, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Girolamo","sequence":"additional","affiliation":[{"name":"Neurophysiopathology Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8706-3386","authenticated-orcid":false,"given":"Marco","family":"Fornaro","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Bari, D.E.T.O, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Amati","sequence":"additional","affiliation":[{"name":"Neurophysiopathology Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lia","sequence":"additional","affiliation":[{"name":"Neurophysiopathology Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Abbracciavento","sequence":"additional","affiliation":[{"name":"A.O.U.C. Policlinico Bari, Clinical Pathology Unit, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"D\u2019Abbicco","sequence":"additional","affiliation":[{"name":"Institute of General Surgery \u201cG Marinaccio\u201d, University of Bari, D.E.T.O, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-5344","authenticated-orcid":false,"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Bari, D.E.T.O, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"2021030705484229100_keaa443-B1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis","volume":"4","author":"Lundberg","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021030705484229100_keaa443-B2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.2009.04190.x","article-title":"Review article: The gastrointestinal complications of myositis","volume":"31","author":"Ebert","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"2021030705484229100_keaa443-B3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00005537-199807000-00009","article-title":"Dysphagia in patients with inclusion body myositis","volume":"108","author":"Houser","year":"1998","journal-title":"Laryngoscope"},{"key":"2021030705484229100_keaa443-B4","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00415-009-5229-9","article-title":"Detecting dysphagia in inclusion body myositis","volume":"256","author":"Cox","year":"2009","journal-title":"J Neurol"},{"key":"2021030705484229100_keaa443-B5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.anl.2009.04.007","article-title":"Polymyositis with dysphagia treated with endoscopic balloon dilatation","volume":"36","author":"Nagano","year":"2009","journal-title":"Auris Nasus Larynx"},{"key":"2021030705484229100_keaa443-B6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3346\/jkms.2009.24.4.715","article-title":"Clinical characteristics and outcomes of juvenile and adult dermatomyositis","volume":"24","author":"Na","year":"2009","journal-title":"J Korean Med Sci"},{"key":"2021030705484229100_keaa443-B7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00455-011-9384-7","article-title":"Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature","volume":"27","author":"Claire Langdon","year":"2012","journal-title":"Dysphagia"},{"key":"2021030705484229100_keaa443-B8","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021030705484229100_keaa443-B9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/gut.52.4.471","article-title":"Biomechanics, diagnosis, and treatment outcome in inflammatory myopathy presenting as oropharyngeal dysphagia","volume":"52","author":"Williams","year":"2003","journal-title":"Gut"},{"key":"2021030705484229100_keaa443-B10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.25507","article-title":"High-resolution manometry in patients with idiopathic inflammatory myopathy: elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset: high-resolution manometry in IIM","volume":"56","author":"Casal-Dominguez","year":"2017","journal-title":"Muscle Nerve"},{"key":"2021030705484229100_keaa443-B11","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/acr.20325","article-title":"Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients","volume":"62","author":"Marie","year":"2010","journal-title":"Arthritis Care Res"},{"key":"2021030705484229100_keaa443-B12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/WNL.58.2.326","article-title":"Intravenous immunoglobulin for dysphagia of inclusion body myositis","volume":"58","author":"Cherin","year":"2002","journal-title":"Neurology"},{"key":"2021030705484229100_keaa443-B13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.semarthrit.2016.07.014","article-title":"Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies","volume":"46","author":"Anh-Tu Hoa","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2021030705484229100_keaa443-B14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"2021030705484229100_keaa443-B15","doi-asserted-by":"crossref","first-page":"e0154746","DOI":"10.1371\/journal.pone.0154746","article-title":"Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies","volume":"11","author":"Mugii","year":"2016","journal-title":"PLoS One"},{"key":"2021030705484229100_keaa443-B16","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","article-title":"Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis","volume":"68","author":"Betteridge","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021030705484229100_keaa443-B17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","article-title":"Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort","volume":"72","author":"Fujimoto","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2021030705484229100_keaa443-B18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2021030705484229100_keaa443-B19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"2021030705484229100_keaa443-B20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"2021030705484229100_keaa443-B21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"2021030705484229100_keaa443-B22","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ)","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2021030705484229100_keaa443-B23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/000348940811701210","article-title":"Validity and reliability of the Eating Assessment Tool (EAT-10)","volume":"117","author":"Belafsky","year":"2008","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2021030705484229100_keaa443-B24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/nan.12040","article-title":"Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis: Beclin 1 expression in s-IBM","volume":"39","author":"Girolamo","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2021030705484229100_keaa443-B25","first-page":"43","volume-title":"Muscle pathology","author":"Bennington","year":"1984"},{"key":"2021030705484229100_keaa443-B26","volume-title":"Muscle biopsy: a modern approach","author":"Dubowitz","year":"1973"},{"key":"2021030705484229100_keaa443-B27","first-page":"165","article-title":"Prognosis of dysphagia in dermatomyositis","volume":"37","author":"Ogawa-Momohara","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2021030705484229100_keaa443-B28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/PHM.0b013e31818a50e2","article-title":"Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome","volume":"87","author":"Oh","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"key":"2021030705484229100_keaa443-B29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10072-011-0814-y","article-title":"A dysphagia study in patients with sporadic inclusion body myositis (s-IBM)","volume":"33","author":"Murata","year":"2012","journal-title":"Neurol Sci"},{"key":"2021030705484229100_keaa443-B30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00455-011-9338-0","article-title":"Dysphagia in inflammatory myopathy: self-report. Incidence, and prevalence","volume":"27","author":"Mulcahy","year":"2012","journal-title":"Dysphagia"},{"key":"2021030705484229100_keaa443-B31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/RHU.0000000000000252","article-title":"Recovery of barium swallow radiographic abnormalities in a patient with dermatomyositis and severe dysphagia after high-dose intravenous immunoglobulins","volume":"21","author":"Iannone","year":"2015","journal-title":"JCR J Clin Rheumatol"},{"key":"2021030705484229100_keaa443-B32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0009-9260(89)80135-7","article-title":"Aspiration of high-density barium contrast medium causing acute pulmonary inflammation\u2014report of two fatal cases in elderly women with disordered swallowing","volume":"40","author":"Gray","year":"1989","journal-title":"Clin Radiol"},{"key":"2021030705484229100_keaa443-B33","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.forsciint.2015.05.016","article-title":"Barium sulfate aspiration: severe chemical pneumonia induced by a massive reflux of contrast medium during small bowel barium enema","volume":"253","author":"Zhang","year":"2015","journal-title":"Forensic Sci Int"},{"key":"2021030705484229100_keaa443-B34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-4486.2006.01292.x","article-title":"Fibreoptic endoscopic evaluation of swallowing and videofluoroscopy: does examination type influence perception of pharyngeal residue severity?","volume":"31","author":"Kelly","year":"2006","journal-title":"Clin Otolaryngol"},{"key":"2021030705484229100_keaa443-B35","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00405-018-5001-9","article-title":"Reliability and validity of the Eating Assessment Tool-10 (Greek adaptation) in neurogenic and head and neck cancer-related oropharyngeal dysphagia","volume":"275","author":"Printza","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2021030705484229100_keaa443-B36","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"2021030705484229100_keaa443-B37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/art.10053","article-title":"Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients","volume":"46","author":"Cherin","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021030705484229100_keaa443-B38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/BOR.0b013e32833f1970","article-title":"Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls","volume":"22","author":"Labirua","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"2021030705484229100_keaa443-B39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0003-9969(01)00042-5","article-title":"Differences in myosin heavy-chain composition between human jaw-closing muscles and supra- and infrahyoid muscles","volume":"46","author":"Korfage","year":"2001","journal-title":"Arch Oral Biol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/3\/1234\/36434307\/keaa443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/3\/1234\/36434307\/keaa443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T05:50:45Z","timestamp":1615096245000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/3\/1234\/5903865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9,10]]},"published-print":{"date-parts":[[2021,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa443","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,9,10]]}}}